Analysts Issue Forecasts for OTCMKTS:GTBIF FY2025 Earnings

Key Points

• Roth Capital has lowered its FY2025 earnings forecast for Green Thumb Industries, now predicting $0.06 per share compared to the previous estimate of $0.19, while the consensus estimate stands at $0.32 per share.
• Green Thumb Industries' stock increased by 2.1%, with a current trading price of $7.13, and a market cap of $1.51 billion.
• In its latest earnings report, the company missed expectations with a quarterly EPS of (0.01), despite revenue of $293.26 million surpassing analyst expectations.

Green Thumb Industries Inc. (OTCMKTS:GTBIF - Free Report) - Investment analysts at Roth Capital reduced their FY2025 earnings estimates for shares of Green Thumb Industries in a note issued to investors on Thursday, August 7th. Roth Capital analyst W. Kirk now forecasts that the company will earn $0.06 per share for the year, down from their prior forecast of $0.19. The consensus estimate for Green Thumb Industries' current full-year earnings is $0.32 per share. Roth Capital also issued estimates for Green Thumb Industries' FY2026 earnings at $0.08 EPS.

Green Thumb Industries Stock Up 2.1%

Shares of GTBIF stock opened at $7.13 on Monday. Green Thumb Industries has a 12-month low of $4.63 and a 12-month high of $12.00. The firm has a market cap of $1.51 billion, a P/E ratio of 64.82 and a beta of 1.18. The company has a 50 day moving average of $5.70 and a 200-day moving average of $5.98.

Green Thumb Industries (OTCMKTS:GTBIF - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.05). Green Thumb Industries had a return on equity of 1.62% and a net margin of 2.51%. The company had revenue of $293.26 million for the quarter, compared to analysts' expectations of $280.66 million.

Green Thumb Industries Company Profile

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.